The Therapeutic Goods Administration (TGA) has invited relevant stakeholders, including the NHAA, for a consultation regarding a proposal to remove Andrographis paniculata (Andrographis) as a permitted ingredient in Listed medicines. This follows several reports of anaphylaxis, which is a life-threatening allergic reaction requiring immediate emergency medical treatment.
